Plus Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.26

+0.03 (+11.12%)

As of Feb 8, 2:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +4,428.7% upside

Low Target $8.46

Average Target $11.77

High Target $14.40

Current Price $0.26

Current
$0.26

Target
$11.77

$8.46 $11.77 avg $14.40

Scenario Analysis

Bear Case

$8.46

3,155.1%

Low target

Base Case

$11.77

+4,428.7%

Avg target

Bull Case

$14.40

+5,440.6%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$10.49

-97.5% from high

52-Week Low

$6.08

+-95.7% from low

Target vs 52W High

$11.77

+12.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%